241 related articles for article (PubMed ID: 20042524)
1. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial.
Nouvenne A; Meschi T; Prati B; Guerra A; Allegri F; Vezzoli G; Soldati L; Gambaro G; Maggiore U; Borghi L
Am J Clin Nutr; 2010 Mar; 91(3):565-70. PubMed ID: 20042524
[TBL] [Abstract][Full Text] [Related]
2. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
[TBL] [Abstract][Full Text] [Related]
3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
4. Dietary interventions for preventing complications in idiopathic hypercalciuria.
Escribano J; Balaguer A; Roqué i Figuls M; Feliu A; Ferre N
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD006022. PubMed ID: 24519664
[TBL] [Abstract][Full Text] [Related]
5. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
Kıraç M; Küpeli B; Irkilata L; Gülbahar O; Aksakal N; Karaoğlan U; Bozkırlı I
Kaohsiung J Med Sci; 2013 Feb; 29(2):88-92. PubMed ID: 23347810
[TBL] [Abstract][Full Text] [Related]
6. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.
Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Leavitt DA; Moeding A; Stessman M; Monga M
Urology; 2012 Feb; 79(2):282-6. PubMed ID: 22000931
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.
Borghi L; Schianchi T; Meschi T; Guerra A; Allegri F; Maggiore U; Novarini A
N Engl J Med; 2002 Jan; 346(2):77-84. PubMed ID: 11784873
[TBL] [Abstract][Full Text] [Related]
10. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?
Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ
Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376
[TBL] [Abstract][Full Text] [Related]
12. Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.
Solak V; Gökce Mİ; Yaman Ö
Int Urol Nephrol; 2021 Sep; 53(9):1791-1796. PubMed ID: 33904027
[TBL] [Abstract][Full Text] [Related]
13. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
14. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria.
Okonkwo OW; Batwara R; Granja I; Asplin JR; Goldfarb DS
PLoS One; 2013; 8(4):e60380. PubMed ID: 23593205
[TBL] [Abstract][Full Text] [Related]
16. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
[TBL] [Abstract][Full Text] [Related]
17. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers.
Bataille P; Achard JM; Fournier A; Boudailliez B; Westeel PF; el Esper N; Bergot C; Jans I; Lalau JD; Petit J
Kidney Int; 1991 Jun; 39(6):1193-205. PubMed ID: 1895673
[TBL] [Abstract][Full Text] [Related]
18. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
19. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
Baggio B; Gambaro G; Favaro S; Borsatti A
Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
